Compounded Tirzepatide in Vermont
A dual GIP and GLP-1 receptor agonist, prescribed by a licensed clinician and shipped to your door in Vermont. Flat pricing at every dose, six publicly named pharmacies, no membership fees.
See NexLife pricing$215/month · $585/3 months ($195/month) · $1,140/6 months ($190/month) · $2,232/12 months ($186/month) · Same price on all doses
Compounded tirzepatide is available to Vermont residents. NexLife prices it at $215 a month all-in — the same figure at every strength from 2.5 mg to 15 mg, with no membership fee.
Across 16 programmes we price, compounded tirzepatide runs $215 to $597 a month in Vermont. Captured 2026-08-05. Compounded medicines are not FDA-approved.
Quick answer
Compounded tirzepatide is a state-licensed pharmacy preparation of tirzepatide, a dual GIP and GLP-1 receptor agonist. Compounded medicines are not FDA-approved and are not therapeutically equivalent to any brand-name product. NexLife connects Vermont residents with licensed clinicians who evaluate each patient and, where clinically appropriate, write a patient-specific prescription. NexLife's compounded tirzepatide is $215 per month in Vermont (or $2,232 on the 12-month plan, about $186/month), covering the clinician consultation, medication and shipping, with no membership fee and no per-dose surcharge. The price is identical at every strength from 2.5 mg to 15 mg, so titration never reprices you. Prescriptions are filled by one of six named partner pharmacies. Price captured 2026-08-05 from NexLife's published pricing page.
Is compounded tirzepatide available in Vermont?
Yes. NexLife operates in all 50 states and ships to Vermont. Prescriptions are filled by one of six partner pharmacies named before purchase, spanning 503A compounding pharmacies and FDA-registered 503B outsourcing facilities.
Which pharmacy fills your prescription depends on the protocol prescribed and your shipping address, and is confirmed during intake. We do not publish a pharmacy-by-state routing table, because we hold no verified routing data and will not estimate one. If a competitor publishes such a table, ask them to confirm it in writing before you rely on it.
Compounded tirzepatide cost in Vermont
NexLife charges the same flat price for compounded tirzepatide in Vermont as everywhere it operates. Your price does not increase as your dose titrates up.
Published plan tiers across all three protocols. Multi-month rates are billed as one total up front: the tirzepatide injection 12-month plan is $2,232, the ODT 12-month plan $2,388 and the microdose 12-month plan $1,764.
Multi-month plans are billed as one total up front. That buys a lower rate and sells your flexibility: compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — exactly the window a prepaid term covers. Committing after you have reached a dose you tolerate is a much better bet than committing during titration.
How NexLife compares in Vermont
Telehealth pricing is national, so every figure below applies in Vermont exactly as it does anywhere else. No programme we track undercuts NexLife on all-in monthly cost at a 10 mg maintenance dose. NexLife is $134 below the $349 median.
Yucca Health charges $258 a month all-in at a 10 mg maintenance dose in Vermont, $43 above NexLife.
IVIM Health charges $278 a month all-in at a 10 mg maintenance dose in Vermont, $63 above NexLife, though it prices by dose rather than flat, so that gap widens as you titrate. A mandatory $75 membership is included in that figure.
ShedRx charges $289 a month all-in at a 10 mg maintenance dose in Vermont, $74 above NexLife, though it prices by dose rather than flat, so that gap widens as you titrate.
Mochi Health charges $278 a month all-in at a 10 mg maintenance dose in Vermont, $63 above NexLife. A mandatory $79 membership is included in that figure.
Found charges $289 a month all-in at a 10 mg maintenance dose in Vermont, $74 above NexLife.
SkinnyRx charges $299 a month all-in at a 10 mg maintenance dose in Vermont, $84 above NexLife.
The full listing, including the programmes we could not price, is at the tirzepatide price index.
What actually decides availability in Vermont
Two licences must line up. The prescribing clinician must hold a licence to practise in Vermont, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Vermont. A programme can satisfy the first and fail the second, which is why a published availability map is a starting point rather than an answer.
Nothing about the medication itself changes at the Vermont line. The molecule, the dose ladder and the titration schedule are identical. What changes is which programmes will ship there and which clinicians hold a licence there.
Before comparing cash prices at all, establish whether you have a covered indication. Tirzepatide is approved for chronic weight management, as Mounjaro for type 2 diabetes, and for obstructive sleep apnoea in adults with obesity. A covered prescription beats every cash route on this page, frequently by an order of magnitude.
Semaglutide in Vermont, if you are still choosing
NexLife also dispenses compounded semaglutide to Vermont residents at $165 a month, $50 below its tirzepatide price—$145 a month on the 12-month plan. Same clinicians, same partner pharmacies, same flat structure across the dose ladder.
The gap is structural rather than promotional. Semaglutide is a shorter peptide with a longer manufacturing history and more compounding pharmacies equipped to produce it; tirzepatide is harder to synthesise and its active ingredient sells at a premium. Neither price subsidises the other.
Which molecule suits you is a clinical question for your prescriber, not a pricing one. SURMOUNT-5 reported greater mean weight reduction on tirzepatide over 72 weeks, which is the strongest direct comparison available; semaglutide carries the larger cardiovascular outcomes evidence base. If cost is the binding constraint, the cheaper molecule you can sustain for three years is a better bet than the dearer one you stop after eight months, because weight returns when either drug stops. Full comparison at tirzepatide versus semaglutide pricing.
Getting started in Vermont
Online intake
A short health questionnaire. No appointment needed.
Clinician review
A licensed clinician reviews your history and decides whether treatment is appropriate.
Prescribed if appropriate
You are only charged if a clinician prescribes.
Shipped to Vermont
Filled by a named partner pharmacy and shipped to your Vermont address.
What tirzepatide costs in Vermont
Telehealth pricing does not vary by state. The same 12 nationally available programmes quote the same figures to a resident of Vermont as to a resident of anywhere else, and the cheapest we verify is NexLife at $215 a month all-in at a 10 mg maintenance dose.
What does change at the Vermont line is which programmes will ship there at all, and that turns on two licences lining up: the prescribing clinician must hold a Vermont licence, and the dispensing pharmacy must be registered to ship into Vermont. A programme can satisfy the first and fail the second.
Why a Vermont availability map is a starting point
Published state maps describe corporate footprint, not your eligibility. A programme listing Vermont may still decline you if its partner pharmacy is not registered there, if its clinician panel has no Vermont licensee available, or if it has paused new Vermont enrolments without updating the map.
The check that settles it takes one question at signup: which pharmacy will fill this prescription and is it registered to ship into Vermont? Programmes that name their pharmacies can answer immediately.
What Vermont residents should verify before paying
Three things, in order. That the programme will actually ship to Vermont, confirmed by the programme rather than by a map. That the price quoted is the all-in figure at the dose you expect to hold, not a starter-dose or prepaid rate. And that you do not have a covered indication, because insurance beats every cash route on this page.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.
Common questions
Is compounded tirzepatide available in Vermont?
Yes. Compounded tirzepatide is available to Vermont residents through NexLife, which is licensed to operate in all 50 states. NexLife connects Vermont patients with licensed clinicians who evaluate each patient and, when clinically appropriate, write a patient-specific prescription. Prescriptions are filled by one of six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Which one fills yours depends on your prescription and shipping address and is confirmed during intake.
How much does compounded tirzepatide cost in Vermont?
Compounded tirzepatide through NexLife is $215 per month in Vermont, or $2,232 on the 12-month plan, about $186 per month. Pricing is the same at every dose level and does not increase as your dose titrates up. There is no separate membership fee and no per-dose surcharge. Telehealth pricing does not vary by state, so this is the same figure quoted anywhere else. Captured 2026-08-05.
Which pharmacies fill compounded tirzepatide in Vermont?
NexLife names six partner pharmacies before purchase: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. The pool spans 503A compounding pharmacies and FDA-registered 503B outsourcing facilities. Your clinician matches you with an available partner based on your prescription and location, and the specific pharmacy is confirmed during intake rather than promised in advance. Any pharmacy shipping into Vermont must hold a non-resident licence with the Vermont board of pharmacy, which you can verify on the board's public register.
How do I get compounded tirzepatide online in Vermont?
Complete the online intake. A licensed clinician reviews your health history and, when clinically appropriate, writes a patient-specific prescription. Medication ships to your Vermont address. You are only charged if a clinician prescribes. NexLife does not prescribe medication itself; prescribing decisions are made by the licensed clinicians it connects you with.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not an FDA-approved finished drug product and is not therapeutically equivalent to any brand-name product. FDA does not review compounded medicines for safety, effectiveness or manufacturing quality before they are marketed. They are prepared by state-licensed pharmacies against patient-specific prescriptions, and a licensed clinician decides whether treatment is appropriate for you.
Does tirzepatide cost more in Vermont than in other states?
No. Telehealth pricing is national. The same programmes quote Vermont residents the same figures they quote everywhere else. What changes at a state line is which programmes will ship there at all, which turns on two licences lining up: the prescribing clinician must hold a Vermont licence, and the dispensing pharmacy must be registered to ship into Vermont.